Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ABC Hydrogel is a clear, amorphous hydrogel wound dressing designed to maintain a moist wound environment, which is essential for optimal healing. It is primarily indicated for the management of chronic and acute wounds, including pressure ulcers (stages I-IV), stasis ulcers, first and second-degree burns, and post-operative incisions. The formulation typically consists of water and glycerin, often supplemented with skin protectants like allantoin. By providing moisture to the wound bed, the gel facilitates autolytic debridement of necrotic tissue and protects the wound from contamination. It is generally classified as a medical device (wound dressing) rather than a systemic pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ABC Hydrogel.